Chargement en cours...
Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis
BACKGROUND: Ankylosing spondylitis (AS) is a chronic immune-mediated disease affecting the sacroiliac joints and the spine, manifesting with new bone formation and osteopenia. Five tumor necrosis factor-alpha (TNF-α) inhibitors (infliximab, etanercept, adalimumab, certolizumab, and golimumab) are av...
Enregistré dans:
| Publié dans: | Medicine (Baltimore) |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer Health
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5484196/ https://ncbi.nlm.nih.gov/pubmed/28640088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000007145 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|